A Phase I Dose Escalation Study of Eribulin Plus Weekly Carboplatin for Metastatic Breast Patients
Clinical trial NCT01795586 · COMPLETED
Trial details
- NCT number
- NCT01795586
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-06
- Primary completion
- 2015-02-24
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.